Quest Diagnostics Incorporated - DGX Net Assets per Single Share

Quest Diagnostics dominates the diagnostics sector thanks to its colossal database reach and IT integration. Analyzing the BVPS, with chart data sourced from GURU.Markets, we see that the value is maintained at 69.88. Quest Diagnostics is implementing genetic innovations for the early detection of pathologies. A streamlined courier network, ensuring the seamless transportation of biomaterials to laboratories, guarantees the business's stability.

DGX: Quest Diagnostics Inc. Net Asset Value per Share 07/04/2022 - 10/27/2026

questdiagnostics.com - analytical breakdowns and key metrics (DGX)

- price and consensus price forecast:

Stock Quotes Quest|DGX - Broker Consensus Forecast

- market capitalization data:

Market Value Quest Diagnostics Incorporated|DGX - Real Price to Acquire Entire Company

- book capitalization data:

Book Value per Share Quest Diagnostics|DGX - Total Stockholders' Equity|Market Capitalization to Book Value Ratio questdiagnostics.com|DGX - Total Business Assets

- debt and liquidity data:

Total Debt to Capital Quest Diagnostics|DGX - Long-Term Debt to Capital|Short-Term Debt to Equity Quest Diagnostics Incorporated|DGX - Company Aggregate Debt|Debts to Book Capitalization Quest Diagnostics Incorporated

Analysis of all company metrics:Quest (DGX)

Manufactured products of Quest Diagnostics Incorporated

Stable demand for laboratory testing at Quest Diagnostics (DGX) ensures a steady inflow of liquidity. This business model is quantified through the difference between the issuer's total assets and liabilities. This metric determines the theoretical value of shareholder equity in the event of a full business liquidation. An increase in this value indicates a strengthening of equity. The price action of the book value per share allows for a real-time assessment of investment protection.

Competitor analysis for Quest Diagnostics

Agilent Tech (A) - Accounting Value per Share|ILMN: Equity per Share|EXAS (Exact Sciences) - Net Assets per Single Share|revvity.com (RVTY) - Accounting Value per Share|Book Value per Share BIO (Bio-Rad)|Net Asset Value per Share Anbio Biotechnology Ltd|Book Value per Share Sterigenics SHC|Equity per Share QuidelOrtho Inc. (QDEL)|Book Value per Share OPK (OPKO Health, Inc.)|CareDx Health - Book Value per Share|Maravai LifeSciences Holdings, Inc. (MRVI) - Net Assets per Single Share|FLGT - Equity per Share|LAB: Book Value per Share|CTKB (Cytek Corp) - Book Value per Share|Net Assets per Single Share OraSure Technologies|Net Assets per Single Share Exagen Diagnostics (XGN)|MDxHealth - Accounting Value per Share|Net Asset Value per Share LUCD (Lucid Diagnostics, Inc.)|Net Assets per Single Share PRE|Net Assets per Share Insight Molecular Diagnostics, Inc. IMDX|Book Value per Share TRIB (Trinity Biotech Corp)|PRPH: Net Assets per Share|Ainos - Net Assets per Single Share|CODX (Co-Diagnostics Inc) - Net Assets per Share|Heart Test Laboratories Inc. - Net Assets per Single Share|Book Value of One Share Biomerica Inc (BMRA)|Accounting Value per Share CDIO|Book Value per Share viraxbiolabs.com (VRAX)|BJDX: Book Value per Share|Aspira Women's Health, Inc. - Net Asset Value per Share|Net Assets per Single Share AXDX (Accelerate Diagnostics, Inc)|Centogene N.V. (CNTG) - Net Assets per Share|ENZ - Accounting Value per Share|Book Price of a Share Fresh2 Group|GENE - Accounting Value per Share|Accounting Value of a Share 23andMe Holding Co|Book Value per Share Psychemedics Corp PMD